Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced neutropenia in patients with urothelial cancer.

Abstract

BACKGROUND A multicenter cooperative study to evaluate clinical usefulness of recombinant human granulocyte colony stimulating factor (rG-CSF; lenograstim) in the treatment of neutropenia associated with cancer chemotherapy was conducted in patients with urothelial cancer. METHODS Therapeutic responses were compared within each patient between the… (More)

Topics

Cite this paper

@article{Kotake1999EffectOR, title={Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced neutropenia in patients with urothelial cancer.}, author={Tatsuro Kotake and M. Usami and T. Miki and Mayuko Togashi and Hisaaki Akaza and Yoshiyuki Kubota and Y Matsumura}, journal={International journal of urology : official journal of the Japanese Urological Association}, year={1999}, volume={6 2}, pages={61-7} }